Of the remaining pathways, Neurotrophin signaling pathway, Insulin signaling pathway, and Type II diabetes mellitus are enriched by target-related proteins of vitexicarpin, suggesting that it may be potentially used for the diabetes therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.